FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210368871> ?p ?o ?g. }

• W3210368871 abstract "Pentavalent antimonial-based chemotherapy is the first-line approach for leishmaniasis treatment and disease control. Nevertheless antimony-resistant parasites have been reported in some endemic regions. Treatment refractoriness is complex and is associated with patient- and parasite-related variables. Although amastigotes are the parasite stage in the vertebrate host and, thus, exposed to the drug, the stress caused by trivalent antimony in promastigotes has been shown to promote significant modification in expression of several genes involved in various biological processes, which will ultimately affect parasite behavior. Leishmania (Viannia) guyanensis is one of the main etiological agents in the Amazon Basin region, with a high relapse rate (approximately 25%).Herein, we conducted several in vitro analyses with L. (V.) guyanensis strains derived from cured and refractory patients after treatment with standardized antimonial therapeutic schemes, in addition to a drug-resistant in vitro-selected strain. Drug sensitivity assessed through Sb(III) half-maximal inhibitory concentration (IC50) assays, growth patterns (with and without drug pressure) and metacyclic-like percentages were determined for all strains and compared to treatment outcomes. Finally, co-cultivation without intercellular contact was followed by parasitic density and Sb(III) IC50 measurements.Poor treatment response was correlated with increased Sb(III) IC50 values. The decrease in drug sensitivity was associated with a reduced cell replication rate, increased in vitro growth ability, and higher metacyclic-like proportion. Additionally, in vitro co-cultivation assays demonstrated that intercellular communication enabled lower drug sensitivity and enhanced in vitro growth ability, regardless of direct cell contact.Data concerning drug sensitivity in the Viannia subgenus are emerging, and L. (V.) guyanensis plays a pivotal epidemiological role in Latin America. Therefore, investigating the parasitic features potentially related to relapses is urgent. Altogether, the data presented here indicate that all tested strains of L. (V.) guyanensis displayed an association between treatment outcome and in vitro parameters, especially the drug sensitivity. Remarkably, sharing enhanced growth ability and decreased drug sensitivity, without intercellular communication, were demonstrated." @default.
• W3210368871 created "2021-11-08" @default.
• W3210368871 creator A5003283003 @default.
• W3210368871 creator A5023015655 @default.
• W3210368871 creator A5025659349 @default.
• W3210368871 creator A5027544648 @default.
• W3210368871 creator A5027775325 @default.
• W3210368871 creator A5029682382 @default.
• W3210368871 creator A5031544051 @default.
• W3210368871 creator A5038221511 @default.
• W3210368871 creator A5076132020 @default.
• W3210368871 creator A5082616055 @default.
• W3210368871 creator A5090746618 @default.
• W3210368871 date "2021-10-28" @default.
• W3210368871 modified "2023-10-17" @default.
• W3210368871 title "Insights from Leishmania (Viannia) guyanensis in vitro behavior and intercellular communication" @default.
• W3210368871 cites W1037986905 @default.
• W3210368871 cites W1490825502 @default.
• W3210368871 cites W1497371772 @default.
• W3210368871 cites W1903629244 @default.
• W3210368871 cites W1935835083 @default.
• W3210368871 cites W1946039171 @default.
• W3210368871 cites W1968391414 @default.
• W3210368871 cites W1969828710 @default.
• W3210368871 cites W1976235047 @default.
• W3210368871 cites W1980721552 @default.
• W3210368871 cites W1982861164 @default.
• W3210368871 cites W1986362532 @default.
• W3210368871 cites W1997231586 @default.
• W3210368871 cites W2007637085 @default.
• W3210368871 cites W2013293252 @default.
• W3210368871 cites W2014172198 @default.
• W3210368871 cites W2015541229 @default.
• W3210368871 cites W2020830292 @default.
• W3210368871 cites W2022068865 @default.
• W3210368871 cites W2024791353 @default.
• W3210368871 cites W2034212614 @default.
• W3210368871 cites W2038206223 @default.
• W3210368871 cites W2039344845 @default.
• W3210368871 cites W2043232610 @default.
• W3210368871 cites W2048263359 @default.
• W3210368871 cites W2067332665 @default.
• W3210368871 cites W2067442540 @default.
• W3210368871 cites W2068541511 @default.
• W3210368871 cites W2071815394 @default.
• W3210368871 cites W2076968232 @default.
• W3210368871 cites W2079386786 @default.
• W3210368871 cites W2082293404 @default.
• W3210368871 cites W2089850488 @default.
• W3210368871 cites W2105851127 @default.
• W3210368871 cites W2106282299 @default.
• W3210368871 cites W2106399556 @default.
• W3210368871 cites W2109458685 @default.
• W3210368871 cites W2112966965 @default.
• W3210368871 cites W2113189468 @default.
• W3210368871 cites W2123230157 @default.
• W3210368871 cites W2127052921 @default.
• W3210368871 cites W2132788729 @default.
• W3210368871 cites W2136256072 @default.
• W3210368871 cites W2141740056 @default.
• W3210368871 cites W2143087307 @default.
• W3210368871 cites W2145469656 @default.
• W3210368871 cites W2154830011 @default.
• W3210368871 cites W2158758064 @default.
• W3210368871 cites W2166738424 @default.
• W3210368871 cites W2168350246 @default.
• W3210368871 cites W2169279305 @default.
• W3210368871 cites W2174366185 @default.
• W3210368871 cites W2186123618 @default.
• W3210368871 cites W2209911727 @default.
• W3210368871 cites W2402675389 @default.
• W3210368871 cites W2470717141 @default.
• W3210368871 cites W2512140590 @default.
• W3210368871 cites W2519753323 @default.
• W3210368871 cites W2522391962 @default.
• W3210368871 cites W2598183298 @default.
• W3210368871 cites W2747731550 @default.
• W3210368871 cites W2767343665 @default.
• W3210368871 cites W2775643792 @default.
• W3210368871 cites W2807345422 @default.
• W3210368871 cites W2809623886 @default.
• W3210368871 cites W286860284 @default.
• W3210368871 cites W2884218973 @default.
• W3210368871 cites W2895283534 @default.
• W3210368871 cites W2896860301 @default.
• W3210368871 cites W2902328751 @default.
• W3210368871 cites W2903103803 @default.
• W3210368871 cites W2914913872 @default.
• W3210368871 cites W2955084268 @default.
• W3210368871 cites W2962004202 @default.
• W3210368871 cites W2968061668 @default.
• W3210368871 cites W2985586364 @default.
• W3210368871 cites W3040218793 @default.
• W3210368871 cites W3159800767 @default.
• W3210368871 cites W4211073781 @default.
• W3210368871 cites W4235829800 @default.
• W3210368871 doi "https://doi.org/10.1186/s13071-021-05057-x" @default.
• W3210368871 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8554959" @default.
• W3210368871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34711290" @default.
• W3210368871 hasPublicationYear "2021" @default.

• next